Michael J. Detke, MD, PhD

Original Research

Duloxetine in the Prevention of Depressive Recurrences: A Randomized, Double-Blind, Placebo-Controlled Trial

May 13, 2009

David G. S. Perahia, Giuseppe Maina, Michael E. Thase, et al

Original Research

A Randomized, Double-Blind Study of Increasing or Maintaining Duloxetine Dose in Patients Without Remission of Major Depressive Disorder After Initial Duloxetine Therapy

September 30, 2008

Susan G. Kornstein, David L. Dunner, Adam L. Meyers, et al

Original Research

Duloxetine Treatment for Role Functioning Improvement in Generalized Anxiety Disorder: Three Independent Studies

April 16, 2007

Jean Endicott, James M. Russell, Joel Raskin, et al

Original Research

Efficacy of Duloxetine for the Treatment of Generalized Anxiety Disorder: Implications for Primary Care Physicians

April 16, 2007

Hannu Koponen, Christer Allgulander, Janelle Erickson, et al

Original Research

The Safety and Tolerability of Duloxetine Compared With Paroxetine and Placebo: A Pooled Analysis of 4 Clinical Trials

August 15, 2006

J. Craig Nelson, Yili Lu, Pritchett, et al

Original Research

Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder

June 15, 2005

Pedro L. Delgado, Stephen K. Brannan, Craig H. Mallinckrodt, et al

Original Research

The Effect of Duloxetine on Painful Physical Symptoms in Depressed Patients: Do Improvements in These Symptoms Result in Higher Remission Rates?

April 1, 2004

Maurizio Fava, Craig H. Mallinckrodt, Michael J. Detke, et al

Original Research

Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary Incontinence

April 1, 2004

Lars Viktrup, Beth A. Pangallo, Michael J. Detke, et al

Original Research

Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression

February 1, 2003

Craig H. Mallinckrodt, David J. Goldstein, Michael J. Detke, et al

Letter to the Editor

Reply to Letter to the Editor "Analgesic Effect of Antidepressants"

January 15, 2003

Michael J. Detke

Original Research

Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial

April 1, 2002

Michael J. Detke, Yili Lu, David J. Goldstein, et al

Duloxetine in the Prevention of Depressive Recurrences: A Randomized, Double-Blind, Placebo-Controlled Trial

A Randomized, Double-Blind Study of Increasing or Maintaining Duloxetine Dose in Patients Without Remission of Major Depressive Disorder After Initial Duloxetine Therapy

Duloxetine Treatment for Role Functioning Improvement in Generalized Anxiety Disorder: Three Independent Studies

Efficacy of Duloxetine for the Treatment of Generalized Anxiety Disorder: Implications for Primary Care Physicians

The Safety and Tolerability of Duloxetine Compared With Paroxetine and Placebo: A Pooled Analysis of 4 Clinical Trials

Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder

The Effect of Duloxetine on Painful Physical Symptoms in Depressed Patients: Do Improvements in These Symptoms Result in Higher Remission Rates?

Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary Incontinence

Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression

Reply to Letter to the Editor "Analgesic Effect of Antidepressants"

Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial

ELSEWHERE:

FOLLOW US:

Michael J. Detke, MD, PhD

Duloxetine in the Prevention of Depressive Recurrences: A Randomized, Double-Blind, Placebo-Controlled Trial

A Randomized, Double-Blind Study of Increasing or Maintaining Duloxetine Dose in Patients Without Remission of Major Depressive Disorder After Initial Duloxetine Therapy

Duloxetine Treatment for Role Functioning Improvement in Generalized Anxiety Disorder: Three Independent Studies

Efficacy of Duloxetine for the Treatment of Generalized Anxiety Disorder: Implications for Primary Care Physicians

The Safety and Tolerability of Duloxetine Compared With Paroxetine and Placebo: A Pooled Analysis of 4 Clinical Trials

Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder

The Effect of Duloxetine on Painful Physical Symptoms in Depressed Patients: Do Improvements in These Symptoms Result in Higher Remission Rates?

Urinary Side Effects of Duloxetine in the Treatment of Depression and Stress Urinary Incontinence

Duloxetine: A New Treatment for the Emotional and Physical Symptoms of Depression

Reply to Letter to the Editor "Analgesic Effect of Antidepressants"

Duloxetine, 60 mg Once Daily, for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles